Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank60
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-20.67%
↑ 87% vs avg
Percentile
P60
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-164.56%
Historical baseline
PeriodValue
2024-20.67%
2023-12.71%
2022-28.60%
2021-97.66%
2020-827.73%
20190.00%